Prestige Pulls Trastuzumab After EMA Knockback

Formal Withdrawal Of MAA Follows CHMP Negative Opinion And Re-Examination

 
• By David Wallace
  
Withdrawal wooden blocks letters
Prestige has withdrawn its HD201 trastuzumab candidate in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products